Brickell Biotech Financials
BBIDelisted Stock | USD 1.79 0.34 23.45% |
Brickell |
Understanding current and past Brickell Biotech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Brickell Biotech's financial statements are interrelated, with each one affecting the others. For example, an increase in Brickell Biotech's assets may result in an increase in income on the income statement.
Brickell Biotech Stock Summary
Brickell Biotech competes with Southwest Airlines, Luxfer Holdings, Ryanair Holdings, Axalta Coating, and NL Industries. Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company was founded in 2009 and is headquartered in Boulder, Colorado. Brickell Biotech operates under Biotechnology classification in the United States and is traded on NCM Exchange. It employs 16 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US10802T1051 |
Business Address | 5777 Central Avenue, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.brickellbio.com |
Phone | 720 505 4755 |
Currency | USD - US Dollar |
Brickell Biotech Key Financial Ratios
Return On Equity | -1.57 | |||
Return On Asset | -0.8 | |||
Target Price | 17.83 | |||
Number Of Employees | 16 | |||
Beta | 0.0796 |
Brickell Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Brickell Biotech's current stock value. Our valuation model uses many indicators to compare Brickell Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brickell Biotech competition to find correlations between indicators driving Brickell Biotech's intrinsic value. More Info.Brickell Biotech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brickell Biotech's earnings, one of the primary drivers of an investment's value.Brickell Biotech Market Pulse
Quote | 1.79 |
Change(%) | 23.45 |
Change | 0.34 |
Open | 1.45 |
Low | 1.42 |
High | 1.98 |
Volume | 0 |
Exchange | NASDAQ |
About Brickell Biotech Financials
What exactly are Brickell Biotech Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Brickell Biotech's income statement, its balance sheet, and the statement of cash flows. Potential Brickell Biotech investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Brickell Biotech investors may use each financial statement separately, they are all related. The changes in Brickell Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Brickell Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Brickell Biotech December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Brickell Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Brickell Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Brickell Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Brickell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Brickell Biotech's daily price indicators and compare them against related drivers.
Information Ratio | (0.06) | |||
Maximum Drawdown | 19.31 | |||
Value At Risk | (8.12) | |||
Potential Upside | 7.3 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Brickell Stock
If you are still planning to invest in Brickell Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brickell Biotech's history and understand the potential risks before investing.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |